Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Increase of Ki-67 index and influence on mortality in patients with neuroendocrine neoplasms

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Photoperiodic co-regulation of kisseptin, neurokinin B and dynorphin in the hypothalamus of a seasonal rodent

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Distribution and seasonal variation in hypothalamic RF-amide peptides in a semi-desert rodent, the jerboa

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mapping of kisspeptin fibres in the brain of the pro-oestrus rat

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Characterization of the uptake of DADLE to isolated nerve terminals - morphine stimulates uptake

    Research output: Contribution to journalConference articleResearchpeer-review

  1. A new uPAR-targeting fluorescent probe for optical guided intracranial surgery in resection of a meningioma-a case report

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Constitutional POLE variants causing a phenotype reminiscent of constitutional mismatch repair deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Brain tumours in children and adolescents may affect the circadian rhythm and quality of life

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Brain tumours result in sleep disorders in children and adolescents

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

An increase in the Ki-67 index in neuroendocrine neoplasms over time in relation to prognosis has scarcely been investigated. We aimed to assess whether the Ki-67 index changed over time and also whether a change influenced prognosis. Second, we investigated the difference in the Ki-67 index between primary tumour and metastases. From 1 January 1995 to 31 December 2019, 108 consecutive patients with gastroenteropancreatic tumours were included. Patients were followed with regard to an increase in the Ki-67 index and all-cause mortality. Ki-67 determination of the primary tumour at diagnosis and at the time of radiological progression, including developed metastases, was performed. A significant increase in the Ki-67 index was defined as a doubling of the value at disease progression compared to the value at diagnosis. In addition, in 14 patients, the Ki-67 index of the primary tumour and present metastases at the time of diagnosis was investigated. At diagnosis, there were no differences in the Ki-67 index between primary tumours and metastases (P = .41). Sixty-five patients had a doubling of the Ki-67 index. The median Ki-67 index at the time of progression 17% (1%-90%) vs 5% (1%-60%) at the time of diagnosis (P = .006). A doubling of the Ki-67 index was independently associated with all-cause mortality (hazard ratio = 2.7 [1.3-6.3], P = 0.02), after adjustment for relevant co-variables including the Ki-67 index at baseline. Doubling of the Ki-67 index at the time of disease progression was associated with a significantly higher risk of all-cause mortality. We recommend that a Ki-67 index is obtained whenever disease progression is recorded by demonstrated progression because it may have impact on the choice of treatment.

Original languageEnglish
Article numbere13018
JournalJournal of Neuroendocrinology
Volume33
Issue number9
Pages (from-to)e13018
ISSN0953-8194
DOIs
Publication statusPublished - 26 Jul 2021

Bibliographical note

© 2021 British Society for Neuroendocrinology.

ID: 68601249